Evaluation of hypoxia in an experimental rat tumour model by [ 18F]Fluoromisonidazole PET and immunohistochemistry

British Journal of Cancer

Volumn 91, Issue 11, 2004, Pages 1947-1954

  Dubois, L ^a,c   Landuyt, W ^a,b   Haustermans, K ^a   Dupont, P ^a   Bormans, G ^a   Vermaelen, P ^a   Flamen, P ^a,d   Verbeken, E ^a   Mortelmans, L ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d JULES BORDET INSTITUTE   (Belgium)

Author keywords

18F FMISO PET; CA IX; Hypoxia; Pimonidazole; Tumour

Indexed keywords

1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; CARBONATE DEHYDRATASE; FLUORINE 18; HYPOXYPROBE 1; MISONIDAZOLE; MONOCLONAL ANTIBODY; NITROIMIDAZOLE DERIVATIVE; PIMONIDAZOLE; TRACER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL MODEL; HYPOXIA; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; ISOTOPE LABELING; MALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOGRAPHY; RAT; RHABDOMYOSARCOMA; TUMOR MODEL; TUMOR VOLUME;

ANIMALS; ANTIBODIES, MONOCLONAL; CARBONIC ANHYDRASE III; CELL HYPOXIA; FLUORODEOXYGLUCOSE F18; HEART; IMMUNOENZYME TECHNIQUES; LUNG; MALE; MISONIDAZOLE; MUSCLES; NITROIMIDAZOLES; POSITRON-EMISSION TOMOGRAPHY; RADIATION-SENSITIZING AGENTS; RADIOPHARMACEUTICALS; RATS; RHABDOMYOSARCOMA;

EID: 11244287240     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6602219     Document Type: Article

References (49)

1. Airley RE, Loncaster J, Raleigh JA, Harris AL, Davidson SE, Hunter RD, West CML, Stratford IJ (2003) Glut-1 and CA IX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding. Int J Cancer 104: 85-91, doi: 10.1002/ijc.10904
2. Ashida S, Nishimori I, Tanimura M, Onishi S, Shuin T (2002) Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma. J Cancer Res Clin Oncol 128: 561-568, doi: 10.1007/s00432-002-0374-x
3. Ballinger JR (2001) Imaging hypoxia in tumors. Semin Nucl Med 4: 321-329, doi: 10.1053/snuc.2001.26191
4. 18F]Fluoro-2- deoxy-D-glucose. Acta Oncol 39: 629-637
5. 2 electrode measurements - Influence of tumour volume and carbogen breathing. Acta Oncol 41: 304-312
6. Brizel DM, Sibley GS, Prosnitz LR, Scher RL, Dewhirst MW (1997) Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 38: 285-289, doi: 10.1016/S0360-3016(97)00101-6
7. Brown JM (1999) The hypoxic cell: a target for selective cancer therapy - Eighteenth Bruce F. Cain Memorial Award Lecture. Cancer Res 59: 5863-5870
8. Bussink J, Kaanders JHAM, Strik AM, Vojnovic B, Van der Kogel AJ (2000) Optical sensor based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines. Radiat Res 154: 547-555, doi: 10.1043/0033-7587(2000)154<0547: OSBOTM>2.0.CO;2
9. Casciari JJ, Graham MM, Rasey JS (1995) A modeling approach for quantifying tumor hypoxia with [F-18]-fluoromisonidazole PET time-activity data. Med Phys 22: 1127-1139
10. Chapman JD (1984) The detection and measurement of hypoxic cells in solid tumors. Cancer 54: 2441-2449
11. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE (1998) Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 46: 229-237, doi: 10.1016/S0167-8140(97)00186-2
12. Cockman ME, Masson N, Mole DR, Jaakkola P, Chang GW, Clifford SC, Maher ER, Pugh CW, Ratcliffe PJ, Maxwell PH (2000) Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J Biol Chem 274: 25733-25741, doi: 10.1074/jbc.M002740200
13. Fyles AW, Milosevic M, Hedley D, Pintilie M, Levin W, Manchul L, Hill RP (2002) Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer. J Clin Oncol 20: 680-687
14. 18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging 31: 513-520, doi: 10.1007/s00259-003-1404-x
15. Haustermans K, Hofland I, Van de Pavert I, Geboes K, Varia M, Raleigh J, Begg AC (2000) Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors. Radiother Oncol 55: 325-333, doi: 10.1016/S0167-8140(00)00206-1
16. Hoebers FJP, Janssen HLK, Valdés Olmos RA, Sprong D, Nunn AD, Balm AJM, Hoefnagel CA, Begg AC, Haustermans KMG (2002) Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99 m BRU 59-21. Eur J Nucl Med 29: 1206-1211, doi: 10.1007/S00259-002-0888-0
17. Janssen HL, Haustermans KM, Sprong D, Blommestijn G, Hofland I, Hoebers FJ, Blijweert E, Raleigh JA, Samenza GL, Varia MA, Balm AJ, Van Velthuysen ML, Delaere P, Sciot R, Begg AC (2002) HIF-1A, pimonidazole, and iododeoxyuridine to estimate hypoxia and perfusion in human head-and-neck tumors. Int J Radiat Oncol Biol Phys 54: 1537-1549, doi: 10.1016/S0360-3016(02)03935-4
18. Kaanders JH, Wijffels KI, Marres HA, Ljungkvist AS, Pop LA, Van der Hoogen FJ, De Wilde PC, Bussink J, Raleigh JA, Van der Kogel AJ (2002) Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Cancer Res 62: 7066-7074
19. Koch CJ (2002) Measurement of absolute oxygen levels in cells and tissues using oxygen sensors and 2-nitroimidazole EF5. Methods Enzymol 352: 3-31
20. Koh W-J, Rasey JS, Evans ML, Grierson JR, Lewellen TK, Graham MM, Krohn KA, Griffin TW (1992) Imaging of hypoxia in human tumors with [F-18]-fluoromisonidazole. Int J Radiat Oncol Biol Phys 22: 199-212
21. Kubota K, Tada M, Yamada S, Hori K, Saito S, Iwata R, Sato K, Fukuda H, Ido T (1999) Comparison of the distribution of fluorine-18 fluoromisonidazole, deoxyglucose and methionine in tumour tissue. Eur J Nucl Med 26: 750-757
22. Landuyt W, Hermans R, Bosmans H, Sunaert S, Beatse E, Farina D, Meijerink M, Zhang H, Van den Bogaert W, Lambin P, Marchal G (2001) BOLD contrast fMRI of whole rodent tumour during air or carbogen breathing using echo-planar imaging at 1.5T. Eur Radiol 11: 2332-2340, doi: 10.1007/s003300100996
23. 18F]Fluoromisonidazole. Appl Radiat Isot 44: 1085-1091
24. Lyng H, Sundfor K, Rofstad EK (1997) Oxygen tension in human tumours measured with polarographic needle electrodes and its relationship to vascular density, necrosis and hypoxia. Radiother Oncol 44: 163-169, doi: 10.1016/S0167-8140(97)01920-8
25. Mason RP, Constantinescu A, Hunjan S, Le D, Hahn EW, Antich PP, Blum C, Peschke P (1999) Regional tumor oxygenation and measurement of dynamic changes. Radiat Res 152: 239-249
26. Nordsmark M, Overgaard J (2000) A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy. Radiother Oncol 57: 39-43, doi: 10.1016/S0167-8140(00)00223-1
27. Olive PL, Aquino-Parsons C, MacPhail SH, Liao S-Y, Raleigh JA, Lerman MI, Stanbridge EJ (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61: 8924-8929
28. Olive PL, Durand RE, Raleigh JA, Luo C, Aquino-Parsons C (2000) Comparison between the comet assay and pimonidazole binding for measuring tumor hypoxia. Br J Cancer 83: 1525-1531, doi: 10.1054/bjoc.2000.1489
29. Pastorekova S, Zavadova Z, Kostal M, Babusikova O, Zavada J (1992) Anovel quasi-viral agent, MaTu, is a two-component system. Virology 187: 620-626
30. 18F]Fluoromisonidazole uptake on oxygen delivery and tissue oxygenation in the porcine liver. Nucl Med Biol 27: 693-700, doi: 10.1016/S0969-8051(00)00151-7
31. Piert M, Machulla HJ, Becker G, Stahlschmidt A, Patt A, Aldinger P, Dissmann PD, Fischer H, Bares R, Becker HD, Lauchart W (1999) Introducing fluorine-18 fluoromisonidazole positron emission tomography for the localisation and quantification of pig liver hypoxia. Eur J Nucl Med 26: 95-109
32. Rajendran JG, Wilson DC, Conrad EU, Peterson LM, Bruckner JD, Rasey JS, Chin LK, Hofstrand PD, Grierson JR, Eary JF, Krohn KA (2003) FMISO and FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging 30: 695-704, doi: 10.1007/S00259-002- 1096-7
33. Raleigh JA, Chou SC, Arteel GE, Horsman MR (1999) Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 51: 580-589
34. Raleigh JA, Chou SC, Bono EL, Thrall DE, Varia MA (2001) Semiquantitative immunohistochemical analysis for hypoxia in human tumors. Int J Radiat Oncol Biol Phys 49: 569-574, doi:10.1016/S0360-3016(00)01505-4
35. Raleigh JA, Koch CJ (1990) Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem Pharmacol 40: 2457-2464
36. Rasey JS, Koh W-J, Grierson JR, Grunbaum Z, Krohn KA (1989) Radiolabeled fluoromisonidazole as an imaging agent for tumor hypoxia. Int J Radiat Oncol Biol Phys 17: 985-991
37. Robinson SP, Howe FA, Rodrigues LM, Stubbs M, Griffiths JR (1998) Magnetic resonance imaging techniques for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol 8: 198-207
38. Stubbs M, McSheehy PM, Griffiths JR, Bashford CL (2000) Causes and consequences of tumour acidity and implications for treatment. Mol Med Today 6: 15-19
39. 18F]Fluoromisonidazole (FMISO). Nucl Med Biol 29: 191-197, doi: 10.1016/S0969-8051(01)00298-0
40. 2 at the cellular level. Br J Cancer 54: 453-457
41. Valk PE, Mathis CA, Prados MD, Gilbert JC, Budinger TF (1992) Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole. J Nucl Med 33: 2133-2137
42. Van de Wiele C, Lahorte C, Oyen W, Boerman O, Goethals I, Slegers G, Dierckx RA (2003) Nuclear medicine imaging to predict response to radiotherapy: a review. Int J Radiat Oncol Biol Phys 55: 5-15, doi: 10.1016/S0360-3016(02) 04122-6
43. Varia MA, Calkins-Adams DP, Rinker LH, Kennedy AS, Novotny DB, Fowler WC, Raleigh JA (1998) Pimonidazole: a novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma. Gyneacol Oncol 71: 270-277, doi: 10.1006/gyno.1998.5163
44. Vaupel P, Kallinowski F, Ohunieff P (1989) Blood flow, oxygen and nutrient supply, and metabolic micro-environment of human tumors: review. Cancer Res 49: 6449-6465
45. 2 tension measurements. Cancer Res 51: 3316-3322
46. Weibel ER (1981) Stereological methods in cell biology: where are we - where are we going? J Histochem Cytochem 29: 1043-1052
47. Workman P, Twentyman P, Balkwill F, Balmain A, Chaplin D, Double J, Embleton J, Newell D, Raymond R, Stables J, Stephens T, Wallace J (1998) United Kingdom Co-ordinating Committee on Cancer Research (UKCCR) guidelines for the Welfare of Animals in Experimental Neoplasia (second edition). Br J Cancer 77: 1-10
48. Wouters BG, Koritzinsky M, Chiu RK, Theys J, Buijsen J, Lambin P (2003) Modulation of cell death in the tumor microenvironment. Semin Radiat Oncol 13: 31-41, doi: 10.1053/srao.2003.50004
49. Wykoff CC, Beasley NJP, Watson PH, Turner KJ, Pastorek J, Sibtain A, Wilson JD, Turley H, Talks KL, Maxwell PH, Pugh CW, Ratcliffe PJ, Harris AL (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60: 7075-7083